Skip to main content
NATERA INC (Common Stock) – ticker 45E
Healthcare · Diagnostics & Research
Made on Aug 21, 2026
Price at call $326.89
6-month call Bear -6.7%
Target by Feb 2027 $305.00
Great value below $240.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -6.7% to $305.00
Predicted High $345.00 at 3 months
Predicted Low $305.00 at 6 months
Max Drawdown (predicted) -6.7%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 21, 2026 1:05 pm
Bear NTRA trends lower to $305.00 (-6.7% from $326.89) by Feb 2027. ride-then-fade
ThesisNTRA rides strong sentiment, blowout Q2, and Druckenmiller endorsement momentum near-term, but stretched valuation (attractive only below $240) and negative value/quality lenses create gravity. Expect a modest melt-up into fall, then drift as narrative digests, with no catalyst to break higher absent next print.
Invalidated ifBreak below $290 on volume, or a sector-wide diagnostics selloff, or negative payer/CMS headline invalidates the momentum leg.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $326.89 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 21, 2026 $326.89 at call The anchor — every point below is measured from this price and date.
2 weeks Sep 4, 2026 $290.54–$363.24 typical range · internal point $335.00 ±11.1% 7/10 Momentum and sentiment carry continues short-term
1 month Sep 21, 2026 $274.22–$379.56 typical range · internal point $342.00 ±16.1% 6/10 Narrative peaks, Druckenmiller halo still active
2 months Oct 21, 2026 $338.00 +3.4% 5/10 Consolidation as buyers exhausted pre-earnings
3 months Nov 21, 2026 $345.00 +5.5% 4/10 Q3 print likely beats, brief pop
4 months Dec 21, 2026 $330.00 +1.0% 4/10 Post-earnings fade, tax-loss rotation elsewhere
5 months Jan 21, 2027 $315.00 -3.6% 4/10 Value gravity, quality concerns weigh
6 months Feb 21, 2027 $305.00 -6.7% 3/10 Drift toward fairer range as narrative cools

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $0.00 (+0.0%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 1 degraded · 6 notes — follow the chain top-down (cause → effect).
  • Degraded
    No usable fair-value anchor — brain-only (anchorless) mode: no v0.3 control line, prediction reasons from lenses/sentiment/regime/price behaviour.
    value_anchor
  • Note
    No positive earnings — traditional DCF and EPV are not applicable
    upstream:classification
  • Note
    Valuation is inherently speculative — based on revenue multiples and growth assumptions
    upstream:classification
  • Note
    Valuation anchor absent: composite_fair_value.
    anchor:composite_fair_value
  • Note
    Valuation anchor absent: dcf.
    anchor:dcf
  • Note
    Valuation anchor absent: anchored_pe.
    anchor:anchored_pe
  • Note
    Valuation anchor absent: signal_adjusted.
    anchor:signal_adjusted

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$326.89
Composite fair value
Signal-adjusted fair value
DCF fair value
Anchored-PE fair value
Buy-below (value lens)
Value net score-69
Value confidence7 / 10
Quality net score-12
Memo confidence— / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 73.1%  3m 55.8%  6m 56.5%  
Daily σ (realism noise)3.5%
Beta vs S&P 500 1m 1.60  3m 1.06  5m 1.28  
Trailing 6-month return50.1%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #8eb3df85c300

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 20, 2026 freshest NTRA-20260820-200742-a93f
ext-forensic-memo Aug 20, 2026 freshest ext-NTRA-20260820-203115-75aa
ext-lens-quality Aug 20, 2026 freshest ext-NTRA-20260820-203115-75aa
ext-lens-sentiment Aug 20, 2026 freshest ext-NTRA-20260820-203115-75aa
ext-lens-value Aug 20, 2026 freshest ext-NTRA-20260820-203115-75aa
scenario-valuation Aug 20, 2026 freshest NTRA-20260820-200742-a93f
valuation-synthesis Aug 20, 2026 freshest NTRA-20260820-200742-a93f

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

1 frozen snapshot — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 21, 2026 v0.6.0 Bear $326.89 $305.00 -6.7% Feb 2027 viewing

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.